Are GLP-1 medications available in Canada?

Yes. Ozempic (semaglutide), Wegovy, Rybelsus, and Mounjaro (tirzepatide) are Health Canada-approved. Coverage varies by provincial drug plan — some provinces cover Ozempic for diabetes but not Wegovy for weight loss. Private insurance coverage varies.

Can I buy peptides online in Canada?

Only from licensed Canadian pharmacies with a valid prescription. Unauthorized online sellers of research peptides are illegal. Health Canada has issued multiple advisories warning about the risks of purchasing peptides from unregulated sources. Always verify the pharmacy is licensed by your provincial pharmacy college.

Legal Disclaimer

This page provides general legal orientation for Canada, not legal advice. Regulations change frequently. Always verify current rules with Health Canada and consult a qualified professional.

Peptide Legal Status in Canada

Moderate

Canada regulates peptides through Health Canada under the Food and Drugs Act. GLP-1 agonists are approved as prescription drugs. Research peptides occupy a regulatory gray area — Health Canada has issued warnings about unauthorized peptide sales but enforcement varies by province. Provincial pharmacy colleges set compounding rules.

Regulator

Health Canada — Official website

Key Facts

Regulatory Stance

moderate

Compounding Allowed

Yes

Telehealth Prescribing

Yes

Compounding Pharmacy Rules

Compounding is regulated at the provincial level by provincial pharmacy colleges (e.g., Ontario College of Pharmacists). Federal compounding policy follows NAPRA Model Standards. Pharmacists may compound for individual patients with a prescription. Health Canada has issued stop-sale orders for unauthorized compounded peptide products.

Telehealth Prescribing

Telehealth prescribing is regulated provincially. Most provinces allow virtual prescribing with a valid doctor-patient relationship. Some provinces require an in-person initial visit. Online pharmacies must be licensed by their provincial pharmacy college. Cross-province prescribing rules vary.

Peptide Categories in Canada

Approved

Semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Saxenda, Victoza) — all Health Canada-approved with DIN (Drug Identification Number).

Research / Unapproved

BPC-157, TB-500, GHRP-2, GHRP-6, ipamorelin, CJC-1295 — not approved by Health Canada. Cannot be legally sold for human use. Health Canada has issued public advisories warning against unauthorized peptide products. Enforcement varies significantly by province.

Banned / Restricted

Peptides scheduled under the Controlled Drugs and Substances Act. Some GHRPs and anabolic-adjacent peptides face enhanced scrutiny. Check current Health Canada scheduling and provincial enforcement priorities.

Key Legislation

Food and Drugs Act (R.S.C., 1985, c. F-27)
Controlled Drugs and Substances Act
Natural Health Products Regulations

Peptides in Canada: FAQ

Sources

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.

Peptide Laws in Other Countries

United Kingdom Australia European Union Singapore United Arab Emirates New Zealand Germany Netherlands France Spain Hong Kong Japan South Korea

Get international legal updates

Stay informed when country-specific legal pages, routing guidance, and safety guidance change.

Free DownloadInternational Peptide Legal GuideGet our free quick reference covering peptide regulations across 14 countries — GLP-1 status, compounding rules, and telehealth access at a glance.PDF

No spam. Unsubscribe anytime.